2Gueyffier F,Boissel JP,Boutitie F,et al.Effect of antihypertensive treatment in patients having already suffered from stroke.Gathering the evidence.The INDANA(Individual Data Analysis of Antihypertensive intervention trials) Project Collaborators[J].Strok
3Antiplatelet Trialists′ Collaboration.Collaborative overview of randomised trials of antiplatelet therapy-I:Prevention of death,myocardial infarction,and stroke by prolonged antiplatelet therapy in various categories of patient[J].BMJ,1994, 314(7088):115
4Kalra L,Perez I,Melbourn A.Stroke risk management:changes in mainstream practice[J].Stroke,1998, 29(1):53-57.
5Brass LM,Krumholz HM,Scinto JM,et al.Waefarin use among patients with artrial fibrillation[J]. Stroke,1997,28(12):2382-2389.
6Hankey GJ.Stroke:how large a public problem,and how can the neurologist help[J].Arch Neurol,1999,56(6):748-754.
7Holloway RG,Benesch C,Rush SR.Stroke prevention narrowing the evidence-practice gap[J].Neurology,2000,54(10):1899-1906.
8Joseph LN,Babikia VL,Allen NC,et al.Risk factor modification in stroke prevention:the experience of a stroke clinic[J].Stroke,1999,30(1):16-20.
9Yusuf S.Two decades of progress in preventing vascular disease[J].Lancet,2002,360(9326):2-3.
